Author name: Waqas Khan

Non-Hodgkin lymphoma (NHL), a cancer affecting the lymphoid tissue, has long been a challenging disease to treat, especially in cases where patients relapse or become refractory to standard therapies. However, recent advancements in immunotherapy, particularly chimeric antigen receptor (CAR)-T cell therapy, have brought new hope to patients and clinicians alike. This groundbreaking treatment has shown

For decades, traditional cancer treatments have been the backbone of oncology care. These approaches include surgery, chemotherapy, and radiation therapy, each playing a critical role in eliminating or controlling cancer growth. Surgery: The First Line of Defense Surgical removal of tumors remains a primary option for many cancer types, particularly when detected early. Surgery aims

Cancer treatment has evolved significantly over the past few decades, with innovations leading to more targeted and effective therapies. One such revolutionary treatment is CAR T-cell therapy, a groundbreaking approach that modifies a patient’s immune cells to better recognize and destroy cancer cells. This method has been recognized as a game-changer in oncology, especially for